Spleen tyrosine kinase (SYK), a non-receptor tyrosine kinase expressed in the cytoplasm, initially identified for its high expression in hematopoietic cells and recognized as a crucial target for the treatment of various autoimmune diseases (Mocsai et al. 2010; Liu and Mamorska-Dyga 2017). Here, SYK is linked to autoimmune disease.